Mayo Clin Proc August 2015 PMID 26205547

Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy.

Jacques Baillargeon, Randall J Urban, Abraham Morgentaler, Charles J Glueck, Gwen Baillargeon, Gulshan Sharma, Yong-Fang Kuo

Download social card

Mentions

19
Peak: 2 in Oct 2024
across 4 sources since Aug 2022

Extended reach

230,032
potential audience

Total likes

124

Video views

3,842

Mentions per month

Aug 2022 – Oct 2024

Where it's discussed

  • Facebook10 posts
  • News6 articles
  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions reflect a balanced acknowledgment of the study's results, with posts citing specific research articles like Baillargeon’s studies, using measured language to discuss risks without sensationalism. This tone indicates a cautious interest that could inform clinical choices without causing alarm or skepticism.

AgreementModerate agreement

Most discussions acknowledge and are aligned with the publication’s findings that testosterone therapy does not substantially increase the risk of VTE, with some references supporting prior research.

InterestModerate interest

The discussions show moderate curiosity, often referencing related studies and praising the thoroughness of the research rather than expressing fascination.

EngagementModerate engagement

Posts demonstrate a reasonable level of engagement through citing specific studies, discussing methodology, or debating clinical implications, though they generally do not delve deeply into the scientific details.

ImpactModerate impact

The collective tone suggests the findings may influence clinical decision-making and trust in testosterone therapy, highlighting a moderate effect on perceptions and practices.

Abstract in brief

  • The study found no increased risk of venous thromboembolism (VTE) in men aged 40 and older who had recently used testosterone therapy, especially within 15 days of the event.
  • Different methods of administering testosterone, such as topical, transdermal, or intramuscular, were not linked to a higher risk of VTE.
  • Overall, filling a prescription for testosterone did not seem to raise the chances of developing VTE in middle-aged and older men, which can help doctors and patients weigh the benefits and risks of treatment.]

Top posts

Most liked on X and Bluesky
Alessandro Loiola MD
@AlessandroLoio2 · X

4. Baillargeon J et al. Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. doi: 10.1177/1060028014539918. 5. Baillargeon J et al. Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy. doi: 10.1016/j.mayocp.2015.05.012. 6. Etminan M et

Oct 24, 2024 · 5 likes · 1 share · 223,646 followers View post →
XLeed
@rogerio_royal · X

RT @AlessandroLoio2: 4. Baillargeon J et al. Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. doi: 10.1177/106002…

Oct 24, 2024 · 1 share · 2,541 followers View post →

All mentions

XLeed
@rogerio_royal · X

RT @AlessandroLoio2: 4. Baillargeon J et al. Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. doi: 10.1177/106002…

Oct 24, 2024 · 1 share · 2,541 followers View post →
Alessandro Loiola MD
@AlessandroLoio2 · X

4. Baillargeon J et al. Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. doi: 10.1177/1060028014539918. 5. Baillargeon J et al. Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy. doi: 10.1016/j.mayocp.2015.05.012. 6. Etminan M et

Oct 24, 2024 · 5 likes · 1 share · 223,646 followers View post →